Bulk Manufacturer of Controlled Substances Application: Wildlife Laboratories, Inc., 31985-31986 [2014-12792]

Download as PDF Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices DEPARTMENT OF JUSTICE [OMB Number 1140–NEW] Agency Information Collection Activities: Proposed eCollection eComments Requested; Tobacco Inventory Report and Direct Sales Report Bureau of Alcohol, Tobacco, Firearms and Explosives, Department of Justice ACTION: 30-day notice. AGENCY: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 79, Number 63, page 18580 on April 2, 2014, allowing for a 60 day comment period. DATES: The purpose of this notice is to allow for an additional 30 days for public comment until July 3, 2014. FOR FURTHER INFORMATION CONTACT: If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Joseph Fox, Chief, Alcohol and Tobacco Enforcement Branch, Bureau of Alcohol, Tobacco, Firearms and Explosives, 99 New York Avenue NE., Washington, DC 20226. Written comments and/or suggestions can also be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington DC 20503 or email to OIRA_submission@omb.eop.gov. SUPPLEMENTARY INFORMATION: This process is conducted in accordance with 5 CFR 1320.10. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; sroberts on DSK4SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:35 Jun 02, 2014 Jkt 232001 • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1140–NEW (1) Type of Information Collection: New collection. (2) Title of the Form/Collection: Tobacco Inventory Report and Direct Sales Report. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number(s): ATF Form 5200.25 and ATF Form 5200.26. Component: Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other-for-profit. Other: None. Abstract: The amendment of the Contraband Cigarette Trafficking Act (CCTA) requires a person who sells more than 10,000 cigarettes or more than 500 single-unit consumer-sized cans or packages of smokeless tobacco per month and conducts non-face-toface consumer sales must report to ATF specific information regarding their inventory and those sales. These forms will be used to report tobacco inventory and sales and identify persons or businesses that are selling and moving tobacco products illegally. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 3,000 respondents will take 1 hour each month to complete ATF Form 5200.25; and 3,500 respondents will take 30 minutes each month to complete ATF Form 5200.26. The combined estimated total number of respondents for this collection is 6,500. (6) An estimate of the total public burden (in hours) associated with the collection: The estimated public burden associated with this collection is 57,000 hours. It is estimated that respondents PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 31985 for ATF Form 5200.25 will take 36,000 hours annually; and respondents for ATF Form 5200.26 will take 21,000 hours annually. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3E– 405B, Washington, DC 20530. Dated: May 29, 2014. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2014–12821 Filed 6–2–14; 8:45 am] BILLING CODE 4410–FY–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Wildlife Laboratories, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before August 4, 2014. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7(g) of 28 CFR part 0, subpart. R, App. In accordance with 21 CFR 1301.33(a), this is notice that on February 10, 2014, Wildlife Laboratories, Inc., 1230 W. Ash Street, DATES: E:\FR\FM\03JNN1.SGM 03JNN1 31986 Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices Suite D, Windsor, Colorado 80550, applied to be registered as a bulk manufacturer of Carfentanil (9743), a basis class of narcotic controlled substance listed in schedule II. The company plans to manufacture the above listed controlled substance for sale to veterinary pharmacies, zoos, and other animal and wildlife applications. Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–12792 Filed 6–2–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before July 3, 2014. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before July 3, 2014. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.34(a), this is notice that on March 5, 2014, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois sroberts on DSK4SPTVN1PROD with NOTICES Jkt 232001 I I II II II II II II with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–12795 Filed 6–2–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: MALLINCKRODT, LLC ACTION: Notice of application. BILLING CODE 4410–09–P DATES: 17:35 Jun 02, 2014 I [FR Doc. 2014–12793 Filed 6–2–14; 8:45 am] Notice of application. VerDate Mar<15>2010 Gamma Hydroxybutyric Acid (2010). Lysergic acid diethylamide (7315) Heroin (9200) ............................... Cocaine (9041) ............................. Codeine (9050) ............................. Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Morphine (9300) ........................... Schedule Dated: May 28, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. Importer of Controlled Substances Application: Alltech Associates, Inc. SUPPLEMENTARY INFORMATION: Controlled substance The company plans to import these controlled substances for the manufacture of reference standards. Drug Enforcement Administration ACTION: 60015, applied to be registered as an importer of the following basic classes of narcotic or non-narcotic controlled substances: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before August 4, 2014. DATES: DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Hospira By Notice dated December 16, 2013, and published in the Federal Register on January 2, 2014, 79 FR 151, Hospira, 1776 North Centennial Drive, McPherson, Kansas 67460–1247, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Remifentanil (9739), a basic class of controlled substance listed in schedule II. The company plans to import Remifentanil for use in dosage form manufacturing. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Hospira to import the basic class of controlled substance is consistent with the public interest and in accordance with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Hospira to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, and dispensers of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App. In accordance with 21 CFR 1301.33(a), this is notice that on January 16, 2014, Mallinckrodt, LLC., 3600 North Second Street, St. Louis, Missouri 63147, applied to be registered as a bulk manufacturer of the following basic classes of narcotic or nonnarcotic controlled substances: SUPPLEMENTARY INFORMATION: E:\FR\FM\03JNN1.SGM 03JNN1

Agencies

[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Pages 31985-31986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12792]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Wildlife 
Laboratories, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before August 4, 2014.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and dispensers of controlled substances 
(other than final orders in connection with suspension, denial, or 
revocation of registration) has been redelegated to the Deputy 
Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to section 7(g) of 28 CFR 
part 0, subpart. R, App.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
February 10, 2014, Wildlife Laboratories, Inc., 1230 W. Ash Street,

[[Page 31986]]

Suite D, Windsor, Colorado 80550, applied to be registered as a bulk 
manufacturer of Carfentanil (9743), a basis class of narcotic 
controlled substance listed in schedule II.
    The company plans to manufacture the above listed controlled 
substance for sale to veterinary pharmacies, zoos, and other animal and 
wildlife applications.

    Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12792 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P